NIH Awards AVM Biotechnology SBIR Grant to Study AVM0703 Combined with Standard of Care in Non-Hodgkin's Lymphoma (NHL) to Improve Complete Response Rates Without...
SEATTLE--(BUSINESS WIRE)--Aug 25, 2022--
SEATTLE--(BUSINESS WIRE)--Aug 25, 2022--